Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
13.35
-0.09 (-0.67%)
At close: Jun 26, 2026, 4:00 PM EDT
13.35
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:31 PM EDT
Design Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Design Therapeutics stock have an average target of 19.6, with a low estimate of 15 and a high estimate of 22. The average target predicts an increase of 46.82% from the current stock price of 13.35.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Design Therapeutics stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 4 | 4 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 6 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Reiterates $21 | Buy | Reiterates | $21 | +57.30% | Jun 15, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $20 | Buy | Maintains | $20 | +49.81% | May 27, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Reiterates $22 | Buy | Reiterates | $22 | +64.79% | May 19, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $14 → $20 | Buy | Maintains | $14 → $20 | +49.81% | May 18, 2026 |
Unknown Analyst Cantor Fitzgerald No rating | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | May 12, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.36
from -1.22
EPS Next Year
-1.64
from -1.36
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.17 | -1.35 | |
| Avg | -1.36 | -1.64 | |
| Low | -1.63 | -2.04 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.